Sikkim’s Covid toll reaches 122;Active cases stand at 294

GANGTOK, 17 Dec: A death of 62-years-old lady from Namchi, South District has taken the COVID-19 death toll in Sikkim to 122. She was succumbed on her way to Namchi District Hospital on 15 December.

In his daily health bulletin on Thursday, Health Department State IEC Officer, Sonam Gyaltsen Bhutia mentioned that the lady had some complications at home and she succumbed on her way to Namchi District Hospital in an ambulance on 15 December. He added that she was declared brought dead in the hospital and her sample was reported positive for COVID-19 in the rapid antigen testing. He added that it was a COVID death with comorbidities as the patient had the problem of hypertension.

In the meanwhile, Sikkim’s tally of the confirmed cases of COVID-19 has reached 5406 with eight fresh cases reported in the last 24 hours ending 8 AM Thursday. The figure of the discharged patients of COVID-19 in Sikkim has further improved to 4896. There are currently 294 active cases of novel coronavirus in the State, of whom three are currently in ICU facility of COVID dedicated STNM hospital.

It has to be mentioned here that eight new cases of novel coronavirus were reported from the testing of 133 samples on Wednesday. In the RT-PCR testing of 91 samples, six persons were found positive for COVID-19, while other two new cases were reported in the rapid antigen testing 33 samples. All nine samples tested by TrueNat were found negative for COVID-19. Of the eight new cases in the State, seven were reported in East District and one in South District.

New cases reported from in and around the capital are one person from near Paljor Stadium in DPH area, one from SIB quarter in Baluwakhani, one from Ranka Road in Lower Sichey, one from Middle Tathangchen, one from Daragaon, Tadong and one patient admitted in emergency ward of STNM hospital, who has later referred to COVID hospital. Likewise, one from Kyongsa, Gyalshing and another from Chumbung in West District were also found positive for COVID-19.